Affiliation:
1. Laboratory for Radiobiology and Molecular Genetics, Vinča Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovića Alasa 12-14, Vinča, 11351 Belgrade, Serbia
Abstract
Hepatocellular carcinoma (HCC) is one of the most frequent cancers in humans, characterised by a high resistance to conventional chemotherapy, late diagnosis, and a high mortality rate. It is necessary to elucidate the molecular mechanisms involved in hepatocarcinogenesis to improve diagnosis and treatment outcomes. The Runt-related (RUNX) family of transcription factors (RUNX1, RUNX2, and RUNX3) participates in cardinal biological processes and plays paramount roles in the pathogenesis of numerous human malignancies. Their role is often controversial as they can act as oncogenes or tumour suppressors and depends on cellular context. Evidence shows that deregulated RUNX genes may be involved in hepatocarcinogenesis from the earliest to the latest stages. In this review, we summarise the topical evidence on the roles of RUNX gene family members in HCC. We discuss their possible application as non-invasive molecular markers for early diagnosis, prognosis, and development of novel treatment strategies in HCC patients.
Funder
Ministry of Science, Technological Development, and Innovations of the Republic of Serbia
Research Theme “Molecular alterations as prognostic and predictive markers in human malignant tumours”
Reference170 articles.
1. Asafo-Agyei, K.O., and Samant, H. (2023). StatPearls, StatPearls Publishing.
2. Hepatocellular Carcinoma;Llovet;Nat. Rev. Dis. Prim.,2021
3. Hepatocellular Carcinoma: A Review;Balogh;J. Hepatocell. Carcinoma,2016
4. Hepatocellular Carcinoma in the Era of Immunotherapy;Sim;Curr. Probl. Cancer,2018
5. Suresh, D., Srinivas, A.N., Prashant, A., Harikumar, K.B., and Kumar, D.P. (2023). Therapeutic Options in Hepatocellular Carcinoma: A Comprehensive Review. Clin. Exp. Med.